tiprankstipranks
Trending News
More News >
D.N.A Biomedical Solutions Ltd (IL:DNA)
:DNA
Israel Market

Dna Group (DNA) Financial Statements

Compare
0 Followers

Dna Group Financial Overview

Dna Group's market cap is currently 114.05M. The company's EPS TTM is 0.179; its P/E ratio is 5.16; Dna Group is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue 306.00K 306.00K 560.00K 0.00 0.00
Gross Profit 306.00K 306.00K 560.00K 0.00 0.00
Operating Income 20.61M -3.41M -24.33M 9.54M -17.54M
EBITDA -1.51M -2.17M 0.00 0.00 0.00
Net Income 22.10M -1.18M -23.54M 18.37M -19.27M
Balance Sheet
Cash & Short-Term Investments 68.31M 66.70M 65.73M 23.69M 42.00K
Total Assets 104.28M 80.66M 81.99M 54.62M 18.49M
Total Debt 0.00 0.00 0.00 0.00 283.00K
Net Debt -68.31M -66.70M -65.73M -23.69M 241.00K
Total Liabilities 2.81M 1.47M 1.88M 287.00K 10.54M
Stockholders' Equity 101.47M 79.19M 80.11M 54.33M 7.95M
Cash Flow
Free Cash Flow 1.61M -678.00K -354.00K -2.33M -611.00K
Operating Cash Flow 1.61M -678.00K -354.00K -2.33M -611.00K
Investing Cash Flow 0.00 1.30M 854.00K -1.43M 0.00
Financing Cash Flow 0.00 0.00 41.05M 27.40M 280.00K
Currency in ILS

Dna Group Earnings and Revenue History

Dna Group Debt to Assets

Dna Group Cash Flow

Dna Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis